What was the biggest success for international markets in the last year? “Getting our platform installed at one of the most prestigious and technologically advanced hospitals in the world was a success that will have a big impact on the market and business growth globally,” said Jovan Pavićević, International Markets Director. In the short interview below, you can also read what he expects from this year and how he sees Better evolving in the international markets.
Looking back, how would you evaluate the past year? What key milestones or challenges defined 2024 for you?
I would say it was definitely a successful year, as we have added several new markets, including Italy, Lithuania, and Sweden, and have significantly increased our customer base in existing markets. As the Better Platform is a market-agnostic solution, it can be both marketed and implemented anywhere in the world. This is a big plus, as you have unlimited potential, but on the other hand, you can easily lose focus on key markets and priorities. So, balancing between the two, potential and focus, was key for us. We will continue working on this in the future, mainly by creating SaaS products that will be even more agnostic but also more self-sufficient, allowing us to spend time creating even more value for our customers.
What do you consider the most significant successes in your market this year, both in terms of business growth and customer impact?
Getting our platform installed at one of the most prestigious and technologically advanced hospitals in the world – the Karolinska University Hospital – was for sure a success that will have a big impact on the market and business growth, not only in Sweden and in the Nordics but also globally. When you have such an institution using your technology and delivering use cases, it is for sure easier to enter into discussions with others. The Greek National project, which is currently in implementation, is certainly a big success as well and will have a big impact, as it would be the largest national EHR system based on an open platform approach.
How will emerging healthcare and technology trends shape the market next year?
I believe that the idea of Postmodern EHR is now well set on the market. We have the likes of Karolinska, Zürich, Basel – all University Hospitals, The Christie NHS Foundation Trust in the UK, which is the largest cancer trust, and several others, even nations, following this approach. It means it is lifting off. The openEHR community also grew significantly last year with more modellers and experts, and new collaborations, like the one with the HL7 community, can only add to this overarching healthcare IT ecosystem we are all trying to build. Technology-wise, AI will definitely have a major impact, not only from the perspective of the clinical users but also in the development process, simplifying and accelerating application development and delivering value to end-users even more.
What are the key priorities and expectations for the international markets in the next year?
Definitely to expand further, but also to keep our focus, as mentioned earlier. In the international markets, we were primarily going with a more technological approach, solving interoperability challenges, data challenges, and application development. With more end-user solutions developed and implemented in the UK, Switzerland, Spain, and Slovenia, we will start promoting these in other markets as well, together with our implementation partners. These solutions include Medication management, PROMs, Care coordination, and Shared care records. We are also considering opening additional offices in established markets.